EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B

Maroua Fattouche, Salah Belaidi, Oussama Abchir iD, Walid Al-Shaar, Khaled Younes iD, Muneerah Mogren Al-Mogren, Samir Chtita iD, Fatima Soualmia, Majdi Hochlaf iD

Pharmaceuticals · 18.12.2024 · 17 (12) · 1712

DOI: 10.3390/ph17121712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 18.12.2024. Verfasst von Maroua Fattouche und 8 weiteren Autor:innen. Beteiligte Einrichtung: Group of Computational and Medicinal Chemistry, Molecular Chemistry and Environment Laboratory, University of Biskra, BP 145, Biskra 07000, Algeria. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American University of the Middle East, American University of the Middle-East.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: RNA polymerase (NS5B), serves as a crucial target for pharmaceutical interventions aimed at combating the hepatitis C virus (HCV), which poses significant health challenges worldwide. The present research endeavors to explore and implement a variety of advanced molecular modeling techniques that aim to create and identify innovative and highly effective inhibitors that specifically target the RNA polymerase enzyme.

Methods

In this study, a QSAR investigation was carried out on a set of thirty-eight isothiazole derivatives targeting NS5B inhibition and thus hepatitis C virus (HCV) treatment. The research methodology made use of various statistical techniques including multiple linear regression (MLR) and artificial neural networks (ANNs) to develop satisfactory models in terms of internal and external validation parameters, indicating their reliability in predicting the activity of new inhibitors. Accordingly, a series of potent NS5B inhibitors is designed, and their inhibitory potential is confirmed through molecular docking simulations.

Results

These simulations showed that the interactions between these inhibitors and the active site 221 binding pocket of the NS5B protein are hydrophobic and hydrogen bond interactions, as well as carbon–hydrogen bonds and electrostatic interactions. Additionally, these newly formulated compounds displayed favorable ADMET characteristics, with molecular dynamics investigations revealing a stable energetic state and dynamic equilibrium.

Conclusions

Our work highlights the importance of NS5B inhibition for the treatment of HCV.

Schlagwörter

Stichwörter der Autor:innen

ADMETANN-QSARisothiazole derivativesmolecular dockingmolecular dynamicspolymerase NS5B

Autor:innen und Institutionen

  • Group of Computational and Medicinal Chemistry, Molecular Chemistry and Environment Laboratory, University of Biskra, BP 145, Biskra 07000, Algeria.
  • Laboratory of Analytical and Molecular Chemistry, Hassan II University of Casablanca, B.P, 7955 Casablanca, Morocco.
  • College of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.
  • Department of Chemistry, Faculty of Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
  • Process Engineering and Environment Laboratory, University of Science and Technology of Oran (USTO), BP 1503, Oran 31000, Algeria.
  • COSYS/IMSE, Université Gustave Eiffel, Champs-sur-Marne, 77454 Marne-la-Vallée, Cedex 2, France.

ORCID-Profile: Oussama Abchir, Khaled Younes, Samir Chtita, Majdi Hochlaf

Förderung

  • American University of the Middle East
  • American University of the Middle-East

Zitieren

APA

Fattouche, M., Belaidi, S., Abchir, O., Al-Shaar, W., Younes, K., Al-Mogren, M. M., Chtita, S., Soualmia, F., & Hochlaf, M. (2024). ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Pharmaceuticals, 17(12), 1712. https://doi.org/10.3390/ph17121712

Vancouver

Fattouche M, Belaidi S, Abchir O, Al-Shaar W, Younes K, Al-Mogren MM, et al. ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B. Pharmaceuticals. 2024;17(12):1712. doi:10.3390/ph17121712

BibTeX
@article{Fattouche2024,
  author = {Fattouche, Maroua and Belaidi, Salah and Abchir, Oussama and Al-Shaar, Walid and Younes, Khaled and Al-Mogren, Muneerah Mogren and Chtita, Samir and Soualmia, Fatima and Hochlaf, Majdi},
  title = {ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {1712},
  doi = {10.3390/ph17121712}
}
Kostenlos starten →